Go
 

 

Welcome to EudraGMP

EudraGMP is the name for the Community database on manufacturing and import authorisations and Good Manufacturing Practice (GMP) certificates. The European Medicines Agency launched the first release in April 2007 and future releases will include planning of inspections in third countries, alerts for quality defects and in addition it is expected to also include information on Wholesale Distributors as a result of new Community legislation on anti-falsification.

Limited access for the general public to EudraGMP with information from only some EU National Competent Authorities (NCA) has been provided since 30 July 2009 for manufacturing and importation authorisations and GMP certificates, with the exception of any information of a commercially and/or personally confidential nature. The current version of EudraGMP provides access for the general public for all EU NCAs with effect from 1st February 2011.

Please click the button below to enter in EudraGMP.

Read-only access to EudraGMP

EudraGMP greatly improves the sharing of information and coordination of action in the area of authorisations and GMP certificates between national competent authorities by eliminating duplication of work and the administrative paper exchange between national competent authorities. It also provides a future platform for facilitating collaboration with international regulatory partners. Authorisation and certificate formats together with relevant procedures are harmonised and published in the Compilation of Community Procedures.

Information in the EudraGMP database is updated on an ongoing basis and in time it is expected that information on around 10,000 manufacturers and importers in the EEA will be included. Each year more than 3,000 new GMP certificates will need to be entered into the database.

The European legislation does not require mandatory routine GMP inspections for active substance manufacturers (see Questions and Answers, section "EU GMP guide part II Basic requirements for active substances used as starting materials"). Therefore, the absence of a GMP certificate for a manufacturer of active substances in EudraGMP does not automatically mean that the manufacturer does not comply with GMP.

Take the EudraGMP web survey!

Today we have launched a two-week survey to gather feedback on the use of EudraGMP.

We are using the survey to gather information to help us plan the future development of EudraGMP. It includes questions about who uses the website and why they use it. It is also collecting ideas for how the website could be improved. The survey is strictly to gather feedback on the public-facing website interface and not on password-protected applications that may relate to the website.

The survey can be foundhere. It will take no more than five minutes to complete. It is open until Friday 18 May 2012.

 
 
     
 
 
 
The EudraGMP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA. Please click here to get list of NCA's.
[EMA © 2007. EudraGMP 2.1.45P01 build 2012/03/05 09:33:55]